Daniel Chen's most recent trade in Gemini Space Station Inc. - Ordinary Shares- Class A was a trade of 535,714 Class A Common Stock done . Disclosure was reported to the exchange on Sept. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gemini Space Station Inc | Daniel Chen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 535,714 | 535,714 | - | 0 | Class A Common Stock | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 01 Jul 2021 | 1,900 | 118,418 (0%) | 0% | 1.4 | 2,641 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 1,900 | 338,340 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.43 per share. | 01 Jul 2021 | 957 | 117,461 (0%) | 0% | 89.4 | 85,585 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 82.75 per share. | 01 Jul 2021 | 943 | 116,518 (0%) | 0% | 82.7 | 78,033 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 01 Jun 2021 | 1,900 | 118,418 (0%) | 0% | 1.4 | 2,641 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,900 | 340,240 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.99 per share. | 01 Jun 2021 | 959 | 117,459 (0%) | 0% | 80.0 | 76,710 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 79.15 per share. | 01 Jun 2021 | 941 | 116,518 (0%) | 0% | 79.1 | 74,480 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 26 May 2021 | 444 | 116,518 (0%) | 0% | 70 | 31,080 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 900 | 342,140 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 14 May 2021 | 900 | 117,418 (0%) | 0% | 1.4 | 1,251 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.76 per share. | 14 May 2021 | 456 | 116,962 (0%) | 0% | 68.8 | 31,355 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.32 per share. | 05 May 2021 | 469 | 116,518 (0%) | 0% | 62.3 | 29,226 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 950 | 343,040 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 03 May 2021 | 950 | 117,468 (0%) | 0% | 1.4 | 1,321 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.03 per share. | 03 May 2021 | 481 | 116,987 (0%) | 0% | 68.0 | 32,722 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 05 Apr 2021 | 1,900 | 118,418 (0%) | 0% | 1.4 | 2,641 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 1,900 | 343,990 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 82.00 per share. | 05 Apr 2021 | 1,222 | 116,518 (0%) | 0% | 82 | 100,204 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.40 per share. | 05 Apr 2021 | 678 | 117,740 (0%) | 0% | 83.4 | 56,545 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 01 Mar 2021 | 1,900 | 118,418 (0%) | 0% | 1.4 | 2,641 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 1,900 | 345,890 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 90.25 per share. | 01 Mar 2021 | 1,224 | 116,518 (0%) | 0% | 90.3 | 110,466 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.44 per share. | 01 Mar 2021 | 676 | 117,742 (0%) | 0% | 92.4 | 62,489 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 1,900 | 347,790 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 02 Feb 2021 | 1,900 | 118,373 (0%) | 0% | 1.4 | 2,641 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 96.00 per share. | 02 Feb 2021 | 1,226 | 116,473 (0%) | 0% | 96 | 117,696 | Common Stock |
| IGM Biosciences Inc | Daniel Chen | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.40 per share. | 02 Feb 2021 | 674 | 117,699 (0%) | 0% | 96.4 | 64,974 | Common Stock |